Monitor HbA1c levels every three months and escalate treatment if the target is unmet.

Formal Recommendations

Recommendation & Evidence

Recommendation StrengthNone
Evidence LevelNone

Categories

HbA1c monitoringTreatment initiation, intensification, and adjustment
Recommendation No.: 2-2024-035E-036R Guideline No.: 2-2024-035EGuideline: Samoa MOH National Diabetes Guidelines

PICO Question

P

Population

People with type 2 diabetes undergoing treatment

I

Intervention

Monitor HbA1c every 3 months and escalate treatment when the target is not met

C

Comparison

Not explicitly stated

O

Outcome

Achievement of HbA1c target

Evidence Information

Evidence No.-
Evidence-
Evidence LevelNone
Recommendation StrengthNone
Statement TypeFormal Recommendations

Guideline Information

Guideline NameSamoa MOH National Diabetes Guidelines
Guideline No.2-2024-035E
AuthorAlec Ekeroma
Guideline TypeGuideline
Year2024
OrganizationMinistry of Health Samoa
RegionOceania
CountrySamoa
Conflict of InterestNo
DOI
Target Population所有糖尿病患者(包括1型糖尿病、2型糖尿病、妊娠期糖尿病、儿童及青少年),特别是萨摩亚及太平洋人群,包括高危人群(超重/肥胖、有家族史、既往糖尿病史等)
Journal
Recommendation Strength Methodology
Evidence Level Methodology

Other Information

Living GuidelineNo
Rapid AdviceNo
UpdatedNo
Recommendation Count0
Reference Count50
Guideline TopicComprehensive
CategoriesHbA1c monitoring, Treatment initiation, intensification, and adjustment
Created At2026-07-28 17:47:18
Updated At2026-07-28 17:47:18